doi: 10.1017/S0033291709990833 106 KohlerC
95% CI: 1.01, 1.31
6X18: Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, Underwood CR, Egebjerg T, enel P, Stewart GD, Liang YL, Glukhova A, Venugopal H, Christopoulos A, Furness SGB, Miller LJ, Reedtz-Runge S, Langmead CJ, Gloriam DE, Danev R, Sexton PM, Wootten D
Journal: Hormone Research Year: 1990 Link: Access the abstract on Karger Publishers Summary: This review discusses the safety profile of Sermorelin, concluding that it is generally well-tolerated with minimal side effects when used appropriately